Respecare Pharmtech Co., Ltd.

Company Description

Respecare Pharmtech Co., Ltd. striving to build ourselves as an indispensable link in the supply chain management of pharmaceuticals and fine chemicals by offering solutions based on product and service. CRO/OEM/CMO services are also highly recommended. For more info, please visit respecare(dot)com. Leading products:apramycin, ceftiofur HCl, ceftiofur Sodium, Neomycin, Clindamycin, Coenzyme Q10, Simvastatin,atosiban acetate,liraglutide, tilmesartan(CEP),elcatonin,cetrorelix acetate, ganirelix acetate,bivalirudin,Atorvastatin intermediate-M4 (CAS NO.: 125971-96-2) carbetocin,teriparatide, Ibrutinib Intermediate (CAS NO.51067-38-0),ETC. Disclaimer: Users are responsible for all patent related issue for our offered products. The therapeutic use shown against each product is indicative only. Patented Products are available for R&D use only.